Risk factors for incident dementia after stroke and transient ischemic attack

Alzheimer's and Dementia

Volumn 11, Issue 1, 2015, Pages 16-23

  Yang, Jie ^a,b   Wong, Adrian ^c   Wang, Zhaolu ^a   Liu, Wenyan ^a   Au, Lisa ^a   Xiong, Yunyun ^d   Chu, Winnie W C ^a   Leung, Eric Y L ^e   Chen, Sirong ^e   Lau, Christine ^a   Chan, Anne Y Y ^a   Lau, Alexander Y L ^a   Fan, Florence ^a   Ip, Vincent ^a   Soo, Yannie ^a   Leung, Thomas ^a   Ho, Chi L ^e   Wong, Lawrence K S ^a   Mok, Vincent C T ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c THE EDUCATION UNIVERSITY OF HONG KONG   (Hong Kong)

^d NANJING UNIVERSITY   (China)

^e HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

Brain atrophy; PiB PET; Poststroke dementia; Transient ischemic attack; Vascular cognitive impairment

Indexed keywords

ANTIHYPERTENSIVE AGENT; DANAPAROID; INSULIN; ORAL ANTIDIABETIC AGENT; PITTSBURGH COMPOUND B; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; ANILINE DERIVATIVE; BIOLOGICAL MARKER; RADIOPHARMACEUTICAL AGENT; THIAZOLE DERIVATIVE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; INSULIN TREATMENT; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDIAL TEMPORAL LOBE ATROPHY; MEDICAL HISTORY; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; STROKE PATIENT; TEMPORAL LOBE; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER LESION; AGE; BLOOD; BRAIN; CHRONIC DISEASE; COHORT ANALYSIS; COMPLICATION; CROSS-SECTIONAL STUDY; DIAGNOSTIC USE; MIDDLE AGED; PATHOLOGY; PROCEDURES; SCINTISCANNING; SEVERITY OF ILLNESS INDEX; VASCULARIZATION; VERY ELDERLY; WHITE MATTER;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANILINE COMPOUNDS; BIOLOGICAL MARKERS; BRAIN; CHRONIC DISEASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEMENTIA; DIABETES MELLITUS; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TEMPORAL LOBE; THIAZOLES; WHITE MATTER;

EID: 84922771763     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.01.003     Document Type: Article

References (28)

1. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:2672-713.
2. Pendlebury ST. Dementia in patients hospitalized with stroke: rates, time course, and clinico-pathologic factors. Int J Stroke 2012;7:570-81.
3. Barba R, Martinez-Espinosa S, Rodriguez-Garcia E, Pondal M, Vivancos J, Del Ser T. Poststroke dementia: clinical features and risk factors. Stroke 2000;31:1494-501.
4. Leys D, Henon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol 2005;4:752-9.
5. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006;37:2220-41.
6. Liu L, Wang D, Wong KS, Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 2011;42:3651-4.
7. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:2064-89.
8. Chiu HFK, Kee HC, Chung WS, Kwong PK. Reliability and validity of the Cantonese version of mini-mental state examination: a preliminary study. Hong Kong Coll Psychiatry 1994;4:25-8.
9. Wong A, Xiong YY, Kwan PW, Chan AY, Lam WW, Wang K, et al. The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease. Dement Geriatr Cogn Disord 2009;28:81-7.
10. Woo J, Ho SC, Lau J, Yuen YK, Chiu H, Lee HC, et al. The prevalence of depressive symptoms and predisposing factors in an elderly Chinese population. Acta Psychiatr Scand 1994;89:8-13.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000.
12. Wong KS, Li H, Chan YL, Ahuja A, Lam WW, Wong A, et al. Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 2000;31:2641-7.
13. Potter GM, Marlborough FJ, Wardlaw JM. Wide variation in definition, detection, and description of lacunar lesions on imaging. Stroke 2011;42:359-66.
14. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
15. Xiong Y, Yang J, Wong A, Wong CH, Chan SS, Li HH, et al. Operational definitions improve reliability of the age-related white matter changes scale. Eur J Neurol 2011;18:744-9.
16. De Groot JC, De Leeuw FE, Oudkerk M, Van Gijn J, Hofman A, Jolles J, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000;47:145-51.
17. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatr 1992;55:967-72.
18. Mok V, Leung EY, Chu W, Chen S, Wong A, Xiong Y, et al. Pittsburgh compound B binding in poststroke dementia. J Neurol Sci 2010;290:135-7.
19. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN international workshop. Neurology 1993;43:250-60.
20. Wen HM, Mok VC, Fan YH, Lam WW, Tang WK, Wong A, et al. Effect of white matter changes on cognitive impairment in patients with lacunar infarcts. Stroke 2004;35:1826-30.
21. Mok V, Wong KK, Xiong Y, Wong A, Schmidt R, Chu W, et al. Cortical and frontal atrophy are associated with cognitive impairment in age-related confluent white-matter lesion. J Neurol Neurosurg Psychiatry 2011;82:52-7.
22. Pohjasvaara T, Mantyla R, Salonen O, Aronen HJ, Ylikoski R, Hietanen M, et al. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol 2000;57:1295-300.
23. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the NUN study. JAMA 1997;277:813-7.
24. Fein G, Di Sclafani V, Tanabe J, Cardenas V, Weiner MW, Jagust WJ, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000;55:1626-35.
25. Mok V, Xiong Y, Wong KK, Wong A, Schmidt R, Chu WW, et al. Predictors for cognitive decline in patients with confluent white matter hyperintensities. Alzheimer Dement 2012;8:S96-103.
26. Inzitari D, Di Carlo A, Pracucci G, Lamassa M, Vanni P, Romanelli M, et al. Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based stroke registry. Stroke 1998;29:2087-93.
27. Desmond DW, Moroney JT, Sano M, Stern Y. Recovery of cognitive function after stroke. Stroke 1996;27:1798-803.
28. Moorhouse P, Rockwood K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol 2008;7:246-55.